OnCusp Therapeutics Competitors and Similar CompaniesClear all

OnCusp Therapeutics's competitors and similar companies include Seagen, Century Therapeutics and Dendreon.

	OnCusp Therapeutics OnCusp Therapeutics is a biopharmaceutical company that specializes in cancer treatment solutions.	Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.	Century Therapeutics Century Therapeutics is a biotech company that develops therapies to treat cancer.	Dendreon Dendreon Pharmaceuticals (formerly known as Activated Cell Therapy) is a biopharmaceutical company that engages in the development of immunotherapy.
Founding Date	Founding Date 2021	Founding Date 1998	Founding Date 2018	Founding Date 1992
Type	Type Private	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy
Locations	Locations New York, US HQ Shanghai, CN Shanghai, CN	Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more	Locations Philadelphia, US HQ Hamilton, CA Seattle, US	Locations Seal Beach, US HQ Seattle, US Union City, US Tampa, US
Employees	Employees 2519% increase	Employees 3,25622% increase	Employees 107	Employees 6131% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2b (FY, 2022)	Revenue (est.) $109.2m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income ($610.3m) (FY, 2022)	Net income ($9.6m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 125m	Total funding raised $ 164m	Total funding raised $ 410m	Total funding raised N/A